Key result
Nitro-oleic acid during ischemia cuts infarct size ~46% and preserves LV function in mice.
Why the study?
The in vivo generation and therapeutic effects of nitrated fatty acids in myocardial ischaemia and reperfusion injury were not fully characterized.
Does exogenous administration of nitro-oleic acid reduce infarct size and preserve left ventricular function in a murine model of myocardial ischaemia and reperfusion?
Population
C57/BL6 mice subjected to 30 min coronary artery ligation and reperfusion
Comparison
Exogenous OA-NO2 administration vs vehicle treatment
Design
Preclinical in vivo murine model study
Follow-up
30 min reperfusion
Authors
Loading...
Warrants larger-animal validation; leaves open translation to human myocardial ischemia therapy.
Does exogenous administration of nitro-oleic acid reduce infarct size and preserve left ventricular function in a murine model of myocardial ischaemia and reperfusion?
Effect estimate: 46% reduction
Exogenous administration of nitro-oleic acid protects against myocardial ischaemia/reperfusion injury in mice by reducing infarct size and preserving left ventricular function, partly via NFkappaB inhibition.
Rudolph et al. (2009) studied myocardial ischaemia and reperfusion injury. nitro-oleic acid (OA-NO(2)) vs. vehicle was evaluated on infarct size (normalized to area at risk) (46% reduction). Exogenous administration of nitro-oleic acid during ischaemia reduced infarct size by 46% and preserved left ventricular function compared with vehicle-treated mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: